Information about J&L Pharma
My details
*
*
*

J&L Pharma (SRL)

BE 0849.895.390

Justitiestraat 81, 2018 Antwerpen

Company information

Status
Active

Enterprise number

BE0849.895.390

VAT liability
Yes
Established
25-10-2012
Last balance sheet year
2024
Company size
Small 1 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from J&L Pharma

2024 2023 2022 2021
Profit/Loss € 42,364 72 % € 24,588 -22 % € 31,376 -9 % € 34,501
Equity € 358,525 13 % € 316,161 8 % € 291,573 12 % € 260,198
Gross margin € 69,640 65 % € 42,235 -21 % € 53,658 -14 % € 62,062

Publications from J&L Pharma

Date Publication
17-01-2024 Modification(s) Articles of Association (NL)
24-01-2013 Resignations - Appointments (NL)
29-10-2012 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of J&L Pharma?
The VAT number of J&L Pharma is BE 0849.895.390.
Wat is the PEPPOL ID of J&L Pharma?
There is no information available about the PEPPOL ID of J&L Pharma or the company is not yet registered on the PEPPOL network.
When was J&L Pharma founded?
J&L Pharma was founded on 25-10-2012.
What is the address of J&L Pharma?
The current registered office of J&L Pharma is located at Justitiestraat 81, 2018 Antwerpen.
When was the last time J&L Pharma filed their annual financial statements?
The most recent financial statements of J&L Pharma were filed on 24-07-2025.
How many employees does J&L Pharma have?
There are 1 FTEs working at J&L Pharma according to the staff figures in the most recent financial statements.
What is the annual turnover of J&L Pharma?
At the time of its most recent financial statements, J&L Pharma did not publish any turnover figures. J&L Pharma reported a gross margin of €69,639.73.

Sources